Arsenous Acid for Refractory Triple-Negative Breast Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Contact: Study coordinator (Zhong-yu Yuan, MD) · yuanzhy@sysucc.org.cn · 86-20-87343794

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC)

Metastatic Triple-Negative Breast Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Houston, United States

Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With Checkpoint Inhibitor Refractory Metastatic or Unresectable Triple Negative Breast Cancer

Anatomic Stage III Breast Cancer AJCC v8 · Anatomic Stage IV Breast Cancer AJCC v8 · Metastatic Triple-Negative Breast Carcinoma

Abroad (travel likely)RecruitingPHASE2

Atlanta, United States · Buffalo, United States

Probiotics for Abemaciclib-Induced Abdominal Discomfort.

Breast Cancer · Chemotherapy-induced Diarrhea

Abroad (travel likely)RecruitingPHASE2

Taipei, Taiwan

Dalpiciclib With or Without Entinostat and Letrozole in HR+/HER2- Early Breast Cancer

Breast Cancer

Abroad (travel likely)RecruitingPHASE2

Shijiazhuang, China